Last reviewed · How we verify

NCT05717777: THE HEAT

Treatment of Exertional Heatstroke witH icE wAter Soaked Towels

Active, enrolled Last updated 7 August 2025
What this trial tests

trial testing There is no intervention, only observational study in Heat Stroke Exertional in 55 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
12 March 2023
Primary endpoint
31 October 2025
31 October 2025

Quick facts

Lead sponsorErasmus Medical Center
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment55
Start date12 March 2023
Primary completion31 October 2025
Estimated completion31 October 2025
Sites1 location across Netherlands

Drugs / interventions tested

Conditions studied

Sponsor

Erasmus Medical Center

Who can join

18 and older, any sex, with Heat Stroke Exertional or Heat Illness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Exertional heat stroke (EHS) is the most serious form of heat-illness that can occur during sports and exercise. If not recognized and treated immediately mortality rate of EHS is high. Early recognition and initiation of cooling are paramount. If temperature is reduced to \< 40°C within 30 minutes of symptom onset, most patients recover completely. There are several strategies for cooling in EHS, including cooling with rotating in ice water soaked towels which cover the body of a patient. The aim of this research is to investigate the effectiveness and safety of treatment of EHS with ice water soaked towels to lower body temperature.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Erasmus Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05717777.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing